Biocept IncOver The Counter Market:BIOCQ
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biocept Inc | 260.0 | 0.0x | --- |
Item 9 Labs Corp | 10.2K | 0.0x | --- |
Signature Eyewear Inc | 10.0 | 0.0x | -26.18% |
Fuse Medical Inc | 7.3M | 2.7x | +2.06% |
Applied DNA Sciences Inc | 3.8M | -8.0x | --- |
Vivos Therapeutics Inc | 7.1M | -0.2x | --- |
Company Information
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name CNSide. CNSide encompasses a suite of cellular and molecular technologies intended to aid medical professionals in CSF analysis and central nervous system (CNS) disease management in patients with solid tumors. It offers and conducts its commercialized diagnostic assays, which include cell capture and enumeration, immunocytochemistry, fluorescent in situ hybridization (FISH), and next generation sequencing (NGS). It has commercialized its CNSide assays for detecting and characterizing many different carcinomas and melanoma. These assays utilize its dual cellular and ctDNA technology platforms and provide biomarker analysis from a patient’s CSF sample.
Contact Information
- Headquarters
- 9955 Mesa Rim RoadSAN DIEGO, CA, United States 92121
- Phone
- 858-320-8200
- Fax
- 858-320-8225
Executives
- Independent Chairman of the Board
- Bruce Gerhardt
- Chief Operating Officer
- Philippe Marchand
- Principal Accounting Officer, Vice President, Controller
- Robert Walsh
- Chief Legal Officer and Chief Compliance Officer
- Darrell Taylor
- Medical Director
- Nathaniel Sweed
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $260.00 |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 2.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-50.69 |
Book Value | $15.57 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,445.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
